Intelligent Bio Solutions (INBS) Net Income towards Common Stockholders (2020 - 2024)
Historic Net Income towards Common Stockholders for Intelligent Bio Solutions (INBS) over the last 5 years, with Q1 2024 value amounting to -$3.0 million.
- Intelligent Bio Solutions' Net Income towards Common Stockholders rose 5299.49% to -$3.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was -$10.3 million, marking a year-over-year increase of 278.23%. This contributed to the annual value of -$12.6 million for FY2023, which is 5122.42% down from last year.
- Per Intelligent Bio Solutions' latest filing, its Net Income towards Common Stockholders stood at -$3.0 million for Q1 2024, which was up 5299.49% from -$2.0 million recorded in Q4 2023.
- Over the past 5 years, Intelligent Bio Solutions' Net Income towards Common Stockholders peaked at -$846979.0 during Q2 2021, and registered a low of -$6.4 million during Q1 2023.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$2.1 million (2022), whereas its average is -$2.4 million.
- Per our database at Business Quant, Intelligent Bio Solutions' Net Income towards Common Stockholders skyrocketed by 5722.95% in 2022 and then crashed by 37257.35% in 2023.
- Over the past 5 years, Intelligent Bio Solutions' Net Income towards Common Stockholders (Quarter) stood at -$1.1 million in 2020, then plummeted by 33.51% to -$1.4 million in 2021, then tumbled by 48.1% to -$2.1 million in 2022, then rose by 5.13% to -$2.0 million in 2023, then crashed by 47.79% to -$3.0 million in 2024.
- Its last three reported values are -$3.0 million in Q1 2024, -$2.0 million for Q4 2023, and -$2.6 million during Q3 2023.